Clinical Trial Update: Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating montelukast for accelerated atherosclerosis related to air pollution (PM2.5) in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Atherosclerosis, Coronary | Phase 4 | Status: UNKNOWN